X2S fundamentals
SINOPHARM GROUP CO. LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of X2S for the last semiannual is 37.05 B EUR, and it's 6.94% lower compared to the previous semiannual. The net income of H2 23 is 620.23 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM